CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date and just needs a touch-up? - You are also welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute.
Learn more about CAZypedia's misson here and in this article.
Totally new to the CAZy classification? Read this first.
Difference between revisions of "User:Kyle Robinson"
Harry Brumer (talk | contribs) (Created page with "200px|right '''This is an empty template to help you get started with composing your User page.''' You should begin by opening this page for ed...") |
|||
| Line 1: | Line 1: | ||
| − | [[Image:Blank_user-200px.png|200px|right]] | + | [http://www.example.com link title][[Image:Blank_user-200px.png|200px|right]] |
| − | |||
| − | + | Kyle Robinson began his studies at [https://en.wikipedia.org/wiki/McGill_University, McGill University], where he completed his B.Sc. while studying under Prof. Paul Wiseman. He has since been pursuing his PhD at the University of British Columbia under the supervision of Prof. [https://www.cazypedia.org/index.php/User:Steve_Withers, Stephen Withers]. His research focuses on the design of selective mechanism-based inhibitors for glycosyl hydrolases, specifically, sialidases and trans-sialidases from [https://www.cazypedia.org/index.php/Glycoside_Hydrolase_Family_33, Family 33]. | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
<!-- Do not remove this Category tag --> | <!-- Do not remove this Category tag --> | ||
[[Category:Contributors|Robinson,Kyle]] | [[Category:Contributors|Robinson,Kyle]] | ||
Revision as of 12:13, 10 August 2015
Kyle Robinson began his studies at McGill University, where he completed his B.Sc. while studying under Prof. Paul Wiseman. He has since been pursuing his PhD at the University of British Columbia under the supervision of Prof. Stephen Withers. His research focuses on the design of selective mechanism-based inhibitors for glycosyl hydrolases, specifically, sialidases and trans-sialidases from Family 33.